Cardio Diagnostics Holdings is trading 5.78% down at $1.88 amid broad market weakness.
- The S&P 500 is down 0.67%, while the Nasdaq Composite is down 1.49%.
- On August 18, 2026, the company announced the launch of an in-house, high-complexity CLIA-certified laboratory in Iowa City for processing its cardiovascular tests.
- The positive announcement does not directly explain the current decline, which followed an earlier premarket gain.